HIV/AIDS Clinical Trials in Houston

Showing 301-320 of 547 trials

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

NCT02438592

This is an observational study involving retrospective and prospective medical record review covering a total maximum of 104 weeks (24 months) per subject. An Audio Computer- Assisted Self-Interview (ACASI) at study entry will assess demographic and psychosocial variables of study subjects. Data will also be collected to assess clinic level variables. Definitions of engagement, prescription of antiretroviral therapy (ART), and viral suppression in the Continuum of Care (CoC) will utilize common definitions including those by U.S. Department of Health and Human Services (DHHS) and Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB). Data will be collected in a large, simple trial design manner to provide all elements for both the primary and secondary outcomes.

HIV

University of North Carolina, Chapel Hill924 participantsStarted Mar 2015

Aurora, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +11 more locations

COMPLETED< 1 mile

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

NCT02449629

This study uses a transformative multiphasic mixed-methods research design that incorporates elements of the following designs: * Sequential: a secondary data analysis was conducted, using data from ATN 039, ATN 086, and ATN 106, to influence the development of the qualitative interview and quantitative survey instruments for primary data collection. * Convergent parallel: concurrent collection and analysis of both qualitative and quantitative primary data that will be combined to address the study objectives.

Transgender, HIV Continuum of Care

University of North Carolina, Chapel Hill187 participantsStarted Jun 2015

Los Angeles, California, United States • Aurora, Colorado, United States • Washington D.C., District of Columbia, United States +11 more locations

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

HIV/AIDS Trials in Other Cities

Treatment of Chronic Cryptosporidiosis in AIDS Patients

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

Expanded Access Program for Maraviroc At Multiple Centers

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Treatment De-Intensification and Residual HIV-1 in Youth

CDC-ATN Linkage Evaluation

Immunologic Memory (Supp. of ATN 024)

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Other Conditions in Houston